Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blood-brain barrier (BBB) permeability enhancement refers to strategies and mechanisms aimed at increasing the passage of substances from the bloodstream into the brain. The BBB is a highly selective barrier, and enhancing its permeability is a critical target for improving drug delivery to treat neurological diseases. Strategies include modulation of tight junctions, targeting receptor-mediated transport pathways, inhibiting active efflux pumps, using cell-permeating peptides/nanoparticles, and hyperthermia techniques. Approaches must balance efficacy with safety due to risks associated with increased nonspecific entry into neural tissue.
Various, including tight junction modulation, receptor-mediated transport, efflux inhibition, cell-penetrating peptides/nanoparticles, and hyperthermia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood-Brain Barrier Permeability Enhancement (BBB Permeability Enhancement).